Gene expression in 16q is associated with survival and differs between Sørlie breast cancer subtypes
暂无分享,去创建一个
P. Hall | Y. Pawitan | J. Bergh | J. Smeds | J. Bjöhle | S. Klaar | A. Ploner | S. Calza | K. Wennmalm | P. Hall
[1] N. Carter,et al. A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH , 2006, Oncogene.
[2] Yudi Pawitan,et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients , 2006, Breast Cancer Research.
[3] I. Ellis,et al. Chromosome 16 tumor‐suppressor genes in breast cancer , 2006, Genes, chromosomes & cancer.
[4] R. Myers,et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.
[5] L. Staudt,et al. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. , 2005, Blood.
[6] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[8] Nicolas Stransky,et al. Visualizing chromosomes as transcriptome correlation maps: evidence of chromosomal domains containing co-expressed genes--a study of 130 invasive ductal breast carcinomas. , 2005, Cancer research.
[9] Cheryl I. P. Lee,et al. Wavelet transformations of tumor expression profiles reveals a pervasive genome-wide imprinting of aneuploidy on the cancer transcriptome. , 2005, Cancer research.
[10] S. Sugano,et al. A Human Transcriptome , 2004, Science.
[11] Rafael A. Irizarry,et al. A Model-Based Background Adjustment for Oligonucleotide Expression Arrays , 2004 .
[12] Yidong Chen,et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. , 2004, Neoplasia.
[13] S. Batalov,et al. A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] Jorma Isola,et al. Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. , 2003, Cancer research.
[15] David Botstein,et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. , 2003, The American journal of pathology.
[16] Thomas D. Wu,et al. Genome-wide identification of chromosomal regions of increased tumor expression by transcriptome analysis. , 2003, Cancer research.
[17] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[19] Joe W. Gray,et al. Genome Amplification of Chromosome 20 in Breast Cancer , 2003, Breast Cancer Research and Treatment.
[20] S. Ishikawa,et al. Expression imbalance map: a new visualization method for detection of mRNA expression imbalance regions. , 2003, Physiological genomics.
[21] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[22] K. Furge,et al. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data , 2002, Genome Biology.
[23] M. Ringnér,et al. Impact of DNA amplification on gene expression patterns in breast cancer. , 2002, Cancer research.
[24] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Strausberg,et al. A preliminary transcriptome map of non-small cell lung cancer. , 2002, Cancer research.
[26] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[27] W. Linehan,et al. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. , 2001, Cancer research.
[28] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] P. V. van Diest,et al. Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution , 2001, The Journal of pathology.
[30] F. Baas,et al. The Human Transcriptome Map: Clustering of Highly Expressed Genes in Chromosomal Domains , 2001, Science.
[31] G. Church,et al. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression , 2000, Nature Genetics.
[32] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[33] Hongyue Dai,et al. Widespread aneuploidy revealed by DNA microarray expression profiling , 2000, Nature Genetics.
[34] A. Hanby,et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. , 1999, Cancer research.
[35] J. Gudmundsson,et al. Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. , 1998, European journal of cancer.
[36] A. Sigurdsson,et al. Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regions , 1995, International journal of cancer.
[37] M. Vijver,et al. E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.
[38] J. Gray,et al. Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] J Piper,et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] B. Dutrillaux,et al. Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. , 1990, Cancer genetics and cytogenetics.
[41] R. Simon,et al. Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas. , 2006, Cancer research.
[42] Tao Jiang,et al. Genetics and population analysis Haplotype-based linkage disequilibrium mapping via direct data mining , 2005 .
[43] D. Tong,et al. Loss of Heterozygosity on Chromosome 13q: Suggestion of a Candidate Tumor Suppressor Gene in Sporadic Breast Cancer , 2004, Breast Cancer Research and Treatment.
[44] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.